Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography

Aswan University Hospital

Status: Completed

Conditions: IUCD Complication

Treatments: Drug: celecoxib plus lidocaine; Drug: lidocaine; Drug: Celecoxib

Study type: Interventional

Funder types: Other

Identifiers

NCT04505657

aswu/351/5/19

Details and patient eligibility

About

our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography

Full description

hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the cannula; and injection of the dye

Enrollment: 150 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• any patient came for Hysterosalpingography

Exclusion criteria

• any patient has contraindication to Hysterosalpingography

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

150 participants in 3 patient groups

Celecoxib plus lidocaine

Experimental group

Description:

Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure

Treatment:

Drug: celecoxib plus lidocaine

Celecoxib

Active Comparator group

Description:

Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +Sterile water 4 puffs during the procedure

Treatment:

Drug: Celecoxib

lidocaine

Active Comparator group

Description:

placebo to celecoxib administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure

Treatment:

Drug: lidocaine